JP2005526507A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005526507A5 JP2005526507A5 JP2003574839A JP2003574839A JP2005526507A5 JP 2005526507 A5 JP2005526507 A5 JP 2005526507A5 JP 2003574839 A JP2003574839 A JP 2003574839A JP 2003574839 A JP2003574839 A JP 2003574839A JP 2005526507 A5 JP2005526507 A5 JP 2005526507A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- nucleic acid
- cell
- acid molecule
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 50
- 229920001184 polypeptide Polymers 0.000 claims 49
- 102000004196 processed proteins & peptides Human genes 0.000 claims 49
- 238000000034 method Methods 0.000 claims 37
- 150000007523 nucleic acids Chemical class 0.000 claims 27
- 210000004027 cell Anatomy 0.000 claims 24
- 108020004707 nucleic acids Proteins 0.000 claims 24
- 102000039446 nucleic acids Human genes 0.000 claims 24
- 239000000523 sample Substances 0.000 claims 15
- 241001465754 Metazoa Species 0.000 claims 10
- 125000003275 alpha amino acid group Chemical group 0.000 claims 7
- 201000010099 disease Diseases 0.000 claims 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 7
- 230000000694 effects Effects 0.000 claims 6
- 230000007170 pathology Effects 0.000 claims 6
- 239000000126 substance Substances 0.000 claims 5
- 239000003795 chemical substances by application Substances 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 4
- 239000013068 control sample Substances 0.000 claims 4
- 230000001575 pathological effect Effects 0.000 claims 4
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 3
- 108700019146 Transgenes Proteins 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 239000002773 nucleotide Substances 0.000 claims 3
- 125000003729 nucleotide group Chemical group 0.000 claims 3
- 241000238631 Hexapoda Species 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 2
- 230000002159 abnormal effect Effects 0.000 claims 2
- 230000001580 bacterial effect Effects 0.000 claims 2
- 238000012258 culturing Methods 0.000 claims 2
- 210000004962 mammalian cell Anatomy 0.000 claims 2
- 230000003334 potential effect Effects 0.000 claims 2
- 229940124606 potential therapeutic agent Drugs 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- 210000005253 yeast cell Anatomy 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- 239000012636 effector Substances 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- 239000003550 marker Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
Applications Claiming Priority (26)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30950102P | 2001-08-02 | 2001-08-02 | |
| US31029101P | 2001-08-03 | 2001-08-03 | |
| US31095101P | 2001-08-08 | 2001-08-08 | |
| US31129201P | 2001-08-09 | 2001-08-09 | |
| US31197901P | 2001-08-13 | 2001-08-13 | |
| US31220301P | 2001-08-14 | 2001-08-14 | |
| US31315601P | 2001-08-17 | 2001-08-17 | |
| US31320102P | 2001-08-17 | 2001-08-17 | |
| US31370201P | 2001-08-20 | 2001-08-20 | |
| US31403101P | 2001-08-21 | 2001-08-21 | |
| US31446601P | 2001-08-23 | 2001-08-23 | |
| US31540301P | 2001-08-28 | 2001-08-28 | |
| US31585301P | 2001-08-29 | 2001-08-29 | |
| US31650801P | 2001-08-31 | 2001-08-31 | |
| US32393601P | 2001-09-21 | 2001-09-21 | |
| US33807801P | 2001-12-03 | 2001-12-03 | |
| US35465502P | 2002-02-05 | 2002-02-05 | |
| US36176402P | 2002-03-05 | 2002-03-05 | |
| US37382502P | 2002-04-19 | 2002-04-19 | |
| US38098002P | 2002-05-15 | 2002-05-15 | |
| US38097102P | 2002-05-15 | 2002-05-15 | |
| US38103902P | 2002-05-16 | 2002-05-16 | |
| US38376102P | 2002-05-28 | 2002-05-28 | |
| US38388702P | 2002-05-29 | 2002-05-29 | |
| US10/210,130 US20040014053A1 (en) | 2001-08-02 | 2002-08-01 | Novel proteins and nucleic acids encoding same |
| PCT/US2002/024459 WO2003076642A2 (en) | 2001-08-02 | 2002-08-02 | Novel proteins and nucleic acids encoding same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005526507A JP2005526507A (ja) | 2005-09-08 |
| JP2005526507A5 true JP2005526507A5 (enrdf_load_stackoverflow) | 2006-01-05 |
Family
ID=35033282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003574839A Pending JP2005526507A (ja) | 2001-08-02 | 2002-08-02 | 新規タンパク質とコード核酸 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2005526507A (enrdf_load_stackoverflow) |
-
2002
- 2002-08-02 JP JP2003574839A patent/JP2005526507A/ja active Pending